Literature DB >> 8436252

Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus.

A Császár1, H Dieplinger, C Sandholzer, I Karádi, E Juhász, H Drexel, T Halmos, L Romics, J R Patsch, G Utermann.   

Abstract

Patients with Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus are at increased risk of developing atherosclerotic vascular diseases. A variety of lipoprotein abnormalities have been described as being associated with this increased risk. In this study, apo(a) isoform frequencies and lipoprotein(a) [Lp(a)] concentrations were determined in Type 1 and Type 2 diabetic patients in order to investigate a possible contribution of Lp(a) to the increased risk for atherosclerosis in diabetes. No significant differences in plasma Lp(a) concentrations were found in two ethnically different populations (Austrians from the province of Tyrol and Hungarians from Budapest) in either type of diabetes when compared to respective control groups (91 Type 1 and 112 Type 2 diabetic patients vs 202 control subjects in the Hungarian study and 44 Type 1 diabetic and 44 Type 2 diabetic vs 125 control subjects in the Austrian study). There were also no significant apo(a) isoform frequency differences between both patient groups and control subjects in the two study groups. These data, obtained from two large ethnically different populations, provide no evidence of a contribution of Lp(a) to the increased risk for atherosclerosis in diabetes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436252     DOI: 10.1007/bf00399092

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  40 in total

1.  Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis.

Authors:  C Lackner; E Boerwinkle; C C Leffert; T Rahmig; H H Hobbs
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma.

Authors:  G Utermann; H J Menzel; H G Kraft; H C Duba; H G Kemmler; C Seitz
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

3.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.

Authors:  J W McLean; J E Tomlinson; W J Kuang; D L Eaton; E Y Chen; G M Fless; A M Scanu; R M Lawn
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

4.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 6.  Pathogenesis of macrovascular disease in the human diabetic.

Authors:  O P Ganda
Journal:  Diabetes       Date:  1980-11       Impact factor: 9.461

7.  Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma. Indication for an assembly defect.

Authors:  H J Menzel; H Dieplinger; C Lackner; F Hoppichler; J K Lloyd; D R Muller; C Labeur; P J Talmud; G Utermann
Journal:  J Biol Chem       Date:  1990-01-15       Impact factor: 5.157

8.  Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes.

Authors:  S M Haffner; K R Tuttle; D L Rainwater
Journal:  Metabolism       Date:  1992-02       Impact factor: 8.694

9.  Variation in the size of human apolipoprotein(a) is due to a hypervariable region in the gene.

Authors:  G Lindahl; E Gersdorf; H J Menzel; M Seed; S Humphries; G Utermann
Journal:  Hum Genet       Date:  1990-05       Impact factor: 4.132

10.  Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria.

Authors:  H Kapelrud; H J Bangstad; K Dahl-Jørgensen; K Berg; K F Hanssen
Journal:  BMJ       Date:  1991-09-21
View more
  11 in total

1.  Serum lipoprotein (a) in type 1 diabetic children and adolescents: relationships with HbA1c and subclinical complications.

Authors:  D Willems; H Dorchy; D Dufrasne
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

2.  In search of a physiological function of lipoprotein(a): causality of elevated Lp(a) levels and reduced incidence of type 2 diabetes.

Authors:  Sotirios Tsimikas
Journal:  J Lipid Res       Date:  2018-04-02       Impact factor: 5.922

3.  Plasma lipoprotein (a) concentration in diabetes mellitus.

Authors:  J Vendrell; C Gutiérrez; R Pastor; C Richart
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

4.  Serum lipoprotein(a) levels are greater in female than male patients with type-2 diabetes.

Authors:  Manouchehr Nakhjavani; Afsaneh Morteza; Alireza Esteghamati; Omid Khalilzadeh; Ali Zandieh; Reza Safari
Journal:  Lipids       Date:  2010-12-14       Impact factor: 1.880

5.  Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.

Authors:  J Q Purnell; S M Marcovina; J E Hokanson; H Kennedy; P A Cleary; M W Steffes; J D Brunzell
Journal:  Diabetes       Date:  1995-10       Impact factor: 9.461

6.  Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients.

Authors:  K Hirata; K Saku; S Jimi; S Kikuchi; H Hamaguchi; K Arakawa
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

7.  Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes.

Authors:  J Ruiz; J Thillet; T Huby; R W James; D Erlich; P Flandre; P Froguel; J Chapman; P Passa
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

Review 8.  Lipoprotein (a): impact by ethnicity and environmental and medical conditions.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Lars Berglund
Journal:  J Lipid Res       Date:  2015-12-04       Impact factor: 5.922

9.  Lipoprotein (a) and vascular disease in diabetic patients.

Authors:  R W James; M Boemi; C Sirolla; L Amadio; P Fumelli; D Pometta
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

10.  Lipoprotein(a) and cardiovascular disease in diabetic patients.

Authors:  Qibin Qi; Lu Qi
Journal:  Clin Lipidol       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.